IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Bags Manufacturing Contract Using Microreactor Technology

11:29 PM MDT | May 26, 2009 | Deepti Ramesh

Lonza says it has won a manufacturing contract with a big pharma company, and the manufacture of the product will be based on Lonza’s proprietary microreactor technology (MRT), enabling scale-up, clinical trials, and large-scale commercial quantities. Further details of the contract were not disclosed. MRT utilizes continuous flow processes based on plug flow reactors and it requires minimal reagent volumes while offering rapid dynamic responses and robustness, Lonza says. MRT offers new chemical routes, reduced solvent usage, higher yields than...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa